Arcadia Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Arcadia Biosciences

10/11/2022 22:02

* Arcadia Biosciences Inc  RKDA.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 21 cents per share.
    * Revenue fell 21% to $1.88 million from a year ago;
analysts
expected $2.67 million. 
    * Arcadia Biosciences Inc's reported EPS for the quarter was
a
loss of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 8.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Arcadia Biosciences Inc shares had fallen by 41.2% this
quarter and lost 70.2% so far this year.
    * The company reported a quarterly loss of $2.87 million.
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $3.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.21          -0.12          Beat
 Jun. 30 2022      -0.30          -0.20          Beat
 Mar. 31 2022      -0.34          -0.20          Beat
 Dec. 31 2021      -0.30          -0.28          Beat